Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SD

Sean Doyle — 5 Patents

ZYZymogenetics: 3 patents #131 of 284Top 50%
Bristol-Myers Squibb: 2 patents #1,827 of 3,969Top 50%
Seattle, WA: #5,850 of 21,776 inventorsTop 30%
Washington: #19,692 of 76,902 inventorsTop 30%
Overall (All Time): #907,971 of 4,157,543Top 25%
5 Patents All Time
Sean Doyle has been granted 5 US patents while listed as an inventor at Zymogenetics. The first was granted in 2008 and the most recent in February 2025. Sean Doyle ranks #907,971 of 4,157,543 US inventors in our database (top 21.8%). Patent records list Sean Doyle in Seattle, WA, US.

Patents per Year

Patents granted per year, 2008 to 2025Bar chart with a peak of 1 patents in 2008.peak 12008: 1 patents20082010: 1 patents20102013: 1 patents20132022: 1 patents20222025: 1 patents2025

Issued Patents All Time

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12227575 Combination of TIM-4 antagonist and PD-1 antagonist and methods of use Mark J. Selby, Eric M. Chadwick 2025-02-18
11306143 Combination of TIM-4 antagonist and PD-1 antagonist and methods of use Mark J. Selby, Eric M. Chadwick 2022-04-19
8361954 Use of IL-28 and IL-29 to treat cancer and autoimmune disorders Kevin M. Klucher, Pallavur V. Sivakumar, Wayne R. Kindsvogel, Chung Chan 2013-01-29
7786075 Use of IL-28 and IL-29 to treat cancer and autoimmune disorders Kevin M. Klucher, Pallavur V. Sivakumar, Wayne R. Kindsvogel, Chung Chan 2010-08-31 $5,350,000
7351689 Use of IL-28 and IL-29 to treat cancer and autoimmune disorders Kevin M. Klucher, Pallavur V. Sivakumar, Wayne R. Kindsvogel, Chung Chan 2008-04-01 $3,428,000